Načítá se...
Latrepirdine for Alzheimer's disease
BACKGROUND: Current treatments for Alzheimer’s disease (AD) provide modest symptomatic relief but do not slow the progression of the disease. Latrepirdine may modulate several targets involved in AD pathology, including lipid peroxidation, mitochondrial permeability, voltage‐gated calcium ion channe...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2015
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7388906/ https://ncbi.nlm.nih.gov/pubmed/25897825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009524.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|